According to Silen Biotech, the first half of 2026 had revenue of 104 million yuan, up 3.36% year on year; net profit attributable to shareholders of listed companies was 356.513 million yuan, up 8.11% year on year, and 32.97 million yuan in the same period last year; after deducting non-net profit of 31.0832 million yuan, up 8.96% year on year. It is proposed to distribute a cash dividend of 1.2 yuan for every 10 shares, for a total of 12.986,400 yuan. Sailen Bio

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.